EMT in development and disease

Angela Nieto (Alicante, Spain)

Source: ERS Lung Science Conference 2017
Number: 18
Disease area: Airway diseases

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Angela Nieto (Alicante, Spain). EMT in development and disease. ERS Lung Science Conference 2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The mechanism of epithelial-mesenchymal transition (EMT) in pulmonary fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 823s
Year: 2006

Elucidating progression of early cystic fibrosis lung disease
Source: Eur Respir J, 50 (5) 1701916; 10.1183/13993003.01916-2017
Year: 2017



Mesenchymal lineage formation in the lung during development and disease
Source: International Congress 2017 – Molecular pathways in lung development
Year: 2017

The role of infection in the development of chronic lung disease of prematurity
Source: Annual Congress 2007 - Chronic lung disease of prematurity: pathogenesis and outcomes
Year: 2007


Lung organoids reveal epithelial-mesenchymal mechanisms of lung disease and potential therapy
Source: ERS Lung Science Conference 2021
Year: 2021



Markers of angiogenesis in serum are correlating with disease progress in lung cancer
Source: Annual Congress 2006 - Prognostic factors in lung cancer
Year: 2006


Neuroendocrine cells in lung development and disease
Source: Eur Respir Monogr 2021; 91: 44-55
Year: 2021


Angiogenesis in lung development, injury and repair: implications for chronic lung disease of prematurity
Source: Annual Congress 2008 - Physiological year in review
Year: 2008


The role of pathological angiogenesis in the pathogenesis of the chronic inflammatory lung diseases
Source: Annual Congress 2005 - Update on the role of angiogenesis in the pathogenesis and treatment of lung diseases
Year: 2005

The therapeutic potential of the mesenchymal stem cell secretome in a mouse model of chronic inflammatory lung disease
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019

FGFs in lung disease
Source: ERS Lung Science Conference 2017
Year: 2017

The role of epithelial to mesenchymal transition (EMT) in airway remodelling after human lung transplantation
Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon
Year: 2008

The pathogenesis of pre-invasive lesion development
Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis
Year: 2009



The pathogenesis of pre-invasive lesion development
Source: Breathe 2008; 6: 147-152
Year: 2009

Transcription factor FOXF1 induces cancer-associated fibroblast-like phenotype to promote lung cancer progression
Source: Annual Congress 2009 - Pathogenesis of lung cancer
Year: 2009



NEUROD1 is highly expressed in extensive disease small cell lung cancer by promoting migration.
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020

TGF-beta-induced transgelin 1 expression contributes to epithelial-to-mesenchymal transition in lung fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 604s
Year: 2006

Optimising disease models for lung diseases and drug development
Source: International Congress 2015 – Development and application of new approaches for respiratory disease research
Year: 2015